PMID- 38315202 OWN - NLM STAT- MEDLINE DCOM- 20240427 LR - 20240427 IS - 1432-5233 (Electronic) IS - 0940-5429 (Linking) VI - 61 IP - 5 DP - 2024 May TI - Association of pro-inflammatory cytokines, adipokines and hepatokine with incident diabetes in India: a nested case-control study within CARRS cohort. PG - 577-586 LID - 10.1007/s00592-023-02229-2 [doi] AB - AIMS: To study the association of pro-inflammatory markers with incident diabetes in India. METHODS: We did a nested case-control study within the CARRS (Centre for Ardiometabolic Risk Reduction in South Asia) cohort. Of the 5739 diabetes-free individuals at the baseline, 216 participants with incident diabetes and 432 age-, gender- and city-matched controls at 2-year follow-up were included. We measured high sensitive C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), monocyte chemoattractant protein-1 ( MCP-1), adiponectin, leptin and fetuin-A in the stored baseline blood samples. We did multivariate conditional logistic regression to estimate association of inflammatory markers (as quartiles) and incident diabetes. Covariates were baseline fasting plasma glucose (FPG) and lipids, body mass index (BMI), family history of diabetes, smoking and alcohol use. RESULTS: Baseline hsCRP and TNF-alpha were higher, and IL-6 and adiponectin were lower among cases vs. controls. In multivariate conditional logistic regression models, only quartile-3 (odds ratio [OR]: 2.96 [95% CI:1.39, 6.30]) and quartile-4 (OR: 2.58 [95% CI: 1.15, 5.79]) of TNF-alpha and quartile-4 of MCP-1 (OR: 2.55 [95% CI: 1.06, 6.16]) were positively associated with diabetes after adjusting for baseline FPG and BMI. These associations did not remain after adjusting for family history. High level (quartile-4) of IL-6 was negatively associated with diabetes after adjusting for all factors (OR: 0.18 [95% CI: 0.06, 0.55]). CONCLUSIONS: Higher TNF-alpha and MCP-1 levels and lower IL-6 were associated with higher risk of developing diabetes. Better understanding and potential methods of addressing these biomarkers, especially in relation to family history, are needed to address diabetes in South Asians. CI - (c) 2024. Springer-Verlag Italia S.r.l., part of Springer Nature. FAU - Gupta, Ruby AU - Gupta R AUID- ORCID: 0000-0002-8487-6004 AD - Centre for Chronic Disease Control, New Delhi, India. ruby@ccdcindia.org. FAU - Shivashankar, Roopa AU - Shivashankar R AUID- ORCID: 0000-0002-4361-9423 AD - Indian Council for Medical Research, New Delhi, India. FAU - Kondal, Dimple AU - Kondal D AUID- ORCID: 0000-0002-1417-9510 AD - Centre for Chronic Disease Control, New Delhi, India. FAU - Gokulakrishnan, Kuppan AU - Gokulakrishnan K AUID- ORCID: 0000-0003-3167-8239 AD - National Institute of Mental Health and NeuroSciences, Bangalore, India. FAU - Patel, Shivani A AU - Patel SA AUID- ORCID: 0000-0003-0082-5857 AD - Rollins School of Public Health, Emory University, Atlanta, USA. FAU - Ali, Mohammed K AU - Ali MK AUID- ORCID: 0000-0001-7266-2503 AD - Emory Global Diabetes Research Center, Emory University, Atlanta, USA. AD - Department of Family & Preventive Medicine, School of Medicine, Emory University, Atlanta, USA. FAU - Narayan, K M Venkat AU - Narayan KMV AUID- ORCID: 0000-0001-8621-5405 AD - Emory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, USA. FAU - Mohan, Viswanathan AU - Mohan V AUID- ORCID: 0000-0001-5038-6210 AD - Madras Diabetes Research Foundation, Chennai, India. FAU - Tandon, Nikhil AU - Tandon N AUID- ORCID: 0000-0003-4604-1986 AD - All India Institute of Medical Sciences, New Delhi, India. FAU - Prabhakaran, Dorairaj AU - Prabhakaran D AUID- ORCID: 0000-0002-3172-834X AD - Center for Chronic Disease Control, New Delhi, India. LA - eng GR - HHSN268200900026C/HL/NHLBI NIH HHS/United States GR - HHSN268200900026C/HL/NHLBI NIH HHS/United States GR - HHSN268200900026C/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20240205 PL - Germany TA - Acta Diabetol JT - Acta diabetologica JID - 9200299 RN - 0 (Adipokines) RN - 0 (Cytokines) RN - 0 (Biomarkers) RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) RN - 9007-41-4 (C-Reactive Protein) RN - 0 (CCL2 protein, human) SB - IM MH - Humans MH - Male MH - Female MH - Case-Control Studies MH - India/epidemiology MH - Middle Aged MH - *Adipokines/blood MH - Adult MH - Cytokines/blood MH - Diabetes Mellitus, Type 2/epidemiology/blood MH - Biomarkers/blood MH - Chemokine CCL2/blood MH - Interleukin-6/blood MH - Tumor Necrosis Factor-alpha/blood MH - Cohort Studies MH - C-Reactive Protein/analysis MH - Incidence OTO - NOTNLM OT - Adipokines OT - Cytokines OT - Hepatokines OT - Inflammation OT - Lipids OT - T2DM OT - hsCRP EDAT- 2024/02/05 14:44 MHDA- 2024/04/28 07:24 CRDT- 2024/02/05 11:05 PHST- 2023/11/01 00:00 [received] PHST- 2023/12/21 00:00 [accepted] PHST- 2024/04/28 07:24 [medline] PHST- 2024/02/05 14:44 [pubmed] PHST- 2024/02/05 11:05 [entrez] AID - 10.1007/s00592-023-02229-2 [pii] AID - 10.1007/s00592-023-02229-2 [doi] PST - ppublish SO - Acta Diabetol. 2024 May;61(5):577-586. doi: 10.1007/s00592-023-02229-2. Epub 2024 Feb 5.